What is the latest status of the project “AstraZeneca US Manufacturing Expansion”?

The status recorded for “AstraZeneca US Manufacturing Expansion” is planned.

What is the budget and commercial profile for the project “AstraZeneca US Manufacturing Expansion”?

Taiyo normalizes the budget of “AstraZeneca US Manufacturing Expansion” to USD 50000000000.

Where can I verify the source and access all details for “AstraZeneca US Manufacturing Expansion”?

This Taiyo project page references The Globe and Mail along with the original URL (https://www.theglobeandmail.com/investing/markets/stocks/NVS/pressreleases/33563086/azn-commits-usd50b-to-us-manufacturing-expansion-amid-tariff-pressures/). Taiyo standardizes official data into a consistent, searchable project profile.

AstraZeneca US Manufacturing Expansion

Sector: Manufacturing (Industrial) • Location: Gaithersburg, Cambridge, Virginia, Maryland, Massachusetts, California, Indiana, Texas, United States

Source: The Globe and Mail

Project

Planned

AstraZeneca has announced a $50 billion investment plan in the United States to be executed by 2030. The centerpiece is a new multi-billion-dollar manufacturing facility in Virginia, focusing on producing drug substances for weight management and metabolic therapies. The site will use advanced technologies such as AI, automation, and data analytics. The investment also includes expansion of R&D an

Status: Prospective
Sector: Manufacturing (Industrial)
Location: Gaithersburg, Cambridge, Virginia, Maryland, Massachusetts, California, Indiana, Texas, United States of America
Updated: 22 Jul 2026
Source: The Globe and Mail

ConstructChat

Ask ConstructChat about AstraZeneca US Manufacturing Expansion

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information

4 Q

The project “AstraZeneca US Manufacturing Expansion” is an infrastructure initiative in the Manufacturing (Industrial) sector, located in Gaithersburg, Cambridge, Virginia, Maryland, Massachusetts, California, Indiana, Texas, United States. Taiyo aggregates data on it from The Globe and Mail.

Participants

Not available for this record.

Status

Original status	planned
Taiyo status	Prospective
Taiyo last update	2026-07-22

Contact

Not available for this record.

Description

Description	AstraZeneca has announced a $50 billion investment plan in the United States to be executed by 2030. The centerpiece is a new multi-billion-dollar manufacturing facility in Virginia, focusing on producing drug substances for weight management and metabolic therapies. The site will use advanced technologies such as AI, automation, and data analytics. The investment also includes expansion of R&D and manufacturing hubs in Maryland, Massachusetts, California, Indiana, and Texas.
Original sector	Pharmaceutical Manufacturing
Budget

Location

Country	United States of America (USA)
State	Virginia, Maryland, Massachusetts, California, Indiana, Texas
City	Gaithersburg, Cambridge

Source

Source	The Globe and Mail
URL

More Details

Record type	Project
Sector	Manufacturing (Industrial)
Article published date	2025-09-16

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

Every detail on this project
News and media coverage
Technical research

View all details

Free account · no card · lands you back on this project

AstraZeneca US Manufacturing Expansion

Ask ConstructChat about AstraZeneca US Manufacturing Expansion

Project Information FAQ

Project Information

Research

View all details

More Manufacturing (Industrial) projects in United States